2023-03-30T16:58:22+08:00 weekly 1.0 https://ru.prisysbiotech.com/ 2024-11-13T14:57:09+08:00 weekly 0.9 https://ru.prisysbiotech.com/animal-welfare 2024-11-13T14:59:50+08:00 weekly 0.9 https://ru.prisysbiotech.com/translational-research-center 2024-11-13T15:00:03+08:00 weekly 0.9 https://ru.prisysbiotech.com/ophthalmic-disease-research 2023-02-27T15:56:40+08:00 weekly 0.9 https://ru.prisysbiotech.com/co-develop 2024-11-13T14:59:54+08:00 weekly 0.9 https://ru.prisysbiotech.com/respiratory-disease-research 2024-11-13T15:00:03+08:00 weekly 0.9 https://ru.prisysbiotech.com/inflammation-immunology-disorders 2024-11-13T14:59:51+08:00 weekly 0.9 https://ru.prisysbiotech.com/metabolic-syndromes-research 2024-11-13T14:59:52+08:00 weekly 0.9 https://ru.prisysbiotech.com/hematological-disease-research 2024-11-13T15:00:03+08:00 weekly 0.9 https://ru.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-13T14:59:52+08:00 weekly 0.9 https://ru.prisysbiotech.com/download 2024-11-13T15:00:03+08:00 weekly 0.9 https://ru.prisysbiotech.com/fibrosis 2024-11-13T14:59:57+08:00 weekly 0.9 https://ru.prisysbiotech.com/nephrology 2024-11-13T14:59:48+08:00 weekly 0.9 https://ru.prisysbiotech.com/about-us 2024-11-13T14:59:48+08:00 weekly 0.9 https://ru.prisysbiotech.com/contact-us 2023-03-31T16:07:45+08:00 weekly 0.9 https://ru.prisysbiotech.com/newslist-1 2024-11-13T14:59:47+08:00 weekly 0.9 https://ru.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://ru.prisysbiotech.com/blog/ 2023-03-31T15:58:42+08:00 weekly 0.9 https://ru.prisysbiotech.com/pk-pd-adme/ 2023-03-31T15:58:42+08:00 weekly 0.9 https://ru.prisysbiotech.com/safety-evaluation/ 2023-03-31T15:58:42+08:00 weekly 0.9 https://ru.prisysbiotech.com/translation-research/ 2023-03-31T15:58:43+08:00 weekly 0.9 https://ru.prisysbiotech.com/biosafety-research/ 2023-03-31T15:58:43+08:00 weekly 1.0 https://ru.prisysbiotech.com/nhp-pharmacology/ 2024-04-11T12:38:48+08:00 weekly 0.9 https://ru.prisysbiotech.com/clearpoint/ 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/pk-pd-adme/adme.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-13T15:00:34+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-11-13T15:00:04+08:00 weekly 0.8 https://ru.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-13T15:00:03+08:00 weekly 0.8 https://ru.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-13T14:59:57+08:00 weekly 0.8 https://ru.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-13T15:00:09+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-13T15:00:03+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-13T14:59:55+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-13T15:00:03+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/translation-research/translational-studies.html 2024-11-13T14:59:57+08:00 weekly 0.8 https://ru.prisysbiotech.com/translation-research/nhpresources.html 2024-11-13T15:00:03+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-13T15:00:03+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2024-11-13T15:00:25+08:00 weekly 0.8 https://ru.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-13T15:00:09+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-13T14:57:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-13T14:59:56+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-13T14:57:20+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-13T15:00:10+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-13T15:00:03+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2023-03-31T17:00:57+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-13T14:59:57+08:00 weekly 0.8 https://ru.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-13T15:00:18+08:00 weekly 0.8 https://ru.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-13T15:00:24+08:00 weekly 0.8 https://ru.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-13T15:00:03+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-13T15:00:05+08:00 weekly 0.8 https://ru.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-26T20:45:53+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-26T20:45:56+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-11-13T15:00:08+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-26T20:45:59+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-26T20:46:05+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-26T21:05:35+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-26T21:32:23+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-12-07T13:36:14+08:00 weekly 0.8 https://ru.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-07T19:42:57+08:00 weekly 0.8 https://ru.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-04-02T07:13:22+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-02T07:13:25+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-14T02:13:28+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-14T02:13:35+08:00 weekly 0.8 https://ru.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-20T01:57:15+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-13T17:59:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T05:14:07+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T00:37:54+08:00 weekly 0.8 https://ru.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-30T06:39:21+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T19:21:45+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T19:26:20+08:00 weekly 0.8 https://ru.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-03-31T15:58:42+08:00 weekly 0.9 https://ru.prisysbiotech.com/newslist-713850-1 2023-03-31T15:58:42+08:00 weekly 0.9 https://ru.prisysbiotech.com/newslist-713851-1 2024-07-29T22:38:14+08:00 weekly 0.9 https://ru.prisysbiotech.com/newslist-818786-1 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-sot2023-66098744.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/meetprisys-sot2023-66098745.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66098746.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66098747.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66098748.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/gene-therapy-nhp-model-66098749.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66098750.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66098753.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66098757.html 2023-03-31T17:00:56+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66099763.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/gene-therapy-toxicology-66272385.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67518279.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/world-parkinsons-disease-day-67518280.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67518281.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67518282.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67518283.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67518284.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67518285.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67518287.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68104623.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68104625.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68104626.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68104650.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68307134.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-68997779.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-68998060.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-68998298.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-68999772.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69000091.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69001688.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309258.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309259.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309284.html 2023-07-16T21:46:29+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309308.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69654267.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69655203.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/0-70957538.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70957539.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70957540.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70957543.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70957544.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70957546.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321610.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321611.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321612.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321613.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321614.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72676645.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001667.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73536732.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73536733.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74148909.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654830.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74789389.html 2024-11-13T14:59:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75163525.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75163534.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76174315.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77057170.html 2024-11-13T14:59:50+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77703353.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77703972.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79193662.html 2024-11-13T14:59:56+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79193664.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-asthma-model-79193665.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79193668.html 2024-11-13T14:59:54+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79193691.html 2024-11-13T14:59:53+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79414782.html 2024-11-13T14:59:51+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79414783.html 2024-11-13T14:59:51+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79414784.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79533254.html 2024-11-13T14:59:54+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pk-strategies-of-pdc-79533255.html 2024-11-13T14:59:54+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79533262.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79533263.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79533264.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79533265.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79533266.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79533267.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79533268.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79533270.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79533271.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79533273.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79533274.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79533275.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79533276.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79533277.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79533278.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79533279.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79533280.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79533281.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79533283.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79533284.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79533285.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79533286.html 2024-11-13T14:59:52+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79533287.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79533288.html 2024-11-13T14:59:54+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79533289.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79533290.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79533291.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79533292.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79533293.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79533294.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79533295.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79533296.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79533297.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79533298.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79533299.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79533300.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79533301.html 2024-11-13T14:59:52+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79533302.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79533303.html 2024-11-13T14:59:53+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/mrna-based-therapies-past-79533304.html 2024-11-13T14:59:54+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79533305.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79533307.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/mrna-based-therapies-present-79533308.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/significance-principles-and-requirements-of-79533309.html 2024-11-13T14:59:51+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79535764.html 2024-08-07T08:44:40+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656509.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81133275.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81133276.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/human-disease-animal-models-81133277.html 2024-11-13T14:57:17+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/convection-enhanced-delivery-81133278.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/china-experimental-monkey-industry-81133279.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/animal-models-of-human-diseases-81133280.html 2024-11-13T14:57:19+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81133281.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81133282.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81133283.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81133284.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81133286.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81133528.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/compartment-pk-model-81133530.html 2024-11-13T15:00:28+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395280.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82671099.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82671100.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82671101.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82671102.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82671103.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82671105.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82671107.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82671114.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82671440.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83018150.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83028877.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83031832.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84021059.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84021060.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84021061.html 2025-01-20T12:54:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84021064.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84021066.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84021067.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84021087.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84021136.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84021764.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17244895436416000.html 2025-02-27T07:26:03+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244895536505856.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295953061241856.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/animal-models-for-womens-health-17295953075774464.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295953078543360.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295953086915584.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295953101743104.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295953120830464.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295953127990272.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/membranous-nephropathy-model-17295953158415360.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295953209336832.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295953247675392.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295953301038080.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295953367475200.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295953393280000.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295953414726656.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295953428980736.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295953454687232.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295953514374144.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17300817546585088.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17382892934194176.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17382892950479872.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17382892966765568.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17382892990735360.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17382892991767552.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17382893036266496.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17382893071655936.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17382893079503872.html 2025-06-02T17:13:35+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17382893084959744.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17382893141009408.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/intracerebroventricular-icv-injection-17382893186950144.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17382893209428992.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17441462805914624.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17441462811108352.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17441462842975232.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17441462874711040.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17441462885573632.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17441462921896960.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17441462951650304.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17441462952223744.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/key-considerations-for-dosing-volume-17441462957073408.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17441462961169408.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17441463040173056.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17441463092126720.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17493822691206144.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17493822815527936.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17493822836810752.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17493822884652032.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17493823203058688.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-copd-model-17493823633482752.html 2025-09-13T17:59:50+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17528729365931008.html 2025-09-13T17:59:51+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/brain-targeted-drug-delivery-17528729374630912.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17528743354295296.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/the-importance-of-administration-volume-17528743416751104.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17528743574807552.html 2025-09-13T18:38:16+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17528756606510080.html 2025-09-13T18:38:13+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17528756731012096.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537899791098880.html 2025-09-30T06:39:20+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17552112121291776.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17624986469573632.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17624986517742592.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17624986548413440.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17624986585883648.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17624986656498688.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/rfp-template-for-nhp-studies-17624986764010496.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17624986766910464.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17624986778149888.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17624986806805504.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/nhp-renal-biopsy-17624986942481408.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625025378624512.html 2025-12-25T19:21:50+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674618043638784.html 2025-12-25T19:21:51+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674618050765824.html 2025-12-25T19:21:46+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674618064249856.html 2025-12-25T19:21:51+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674618089251840.html 2025-12-25T19:21:52+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674618118710272.html 2025-12-25T19:21:52+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674618185671680.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674628382286848.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674628445234176.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674628465402880.html 2026-01-29T19:26:29+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724160942662656.html 2026-01-29T19:26:25+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724160947184640.html 2026-01-29T19:26:24+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724160984605696.html 2026-01-29T19:26:24+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724160989537280.html 2026-01-29T19:26:18+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724161028137984.html 2026-01-29T19:26:18+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724161029776384.html 2026-01-29T19:26:19+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724161053893632.html 2026-01-29T19:26:17+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724161097049088.html 2026-01-29T19:26:27+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724161796957184.html 2026-03-27T17:52:49+08:00 weekly 0.8 https://ru.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724178182579200.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://ru.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://ru.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://ru.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://ru.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://ru.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://ru.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html